30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Lucid Diagnostics Inc (LUCD)

Track

Over the last 90 days, Lucid Diagnostics Inc. has seen one insider buy transaction totaling $245,270. This contrasts with earlier periods showing multiple sell transactions by another insider. The company's stock has experienced a significant price decrease of 33.8% over the past 90 days, trading near its 52-week low.
Stock chart
Ticker: LUCD Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Matheis Dennis
1 purchase — total 245,270 USD
Buy 20 May 2026
Value US$4,897,925.34 | Price 128.43 | Shares 29,043
Buy 20 Aug 2025
Value US$2,256,960.27 | Price 259.87 | Shares 44,117
Buy 22 May 2025
Value US$43,794.61 | Price 1.32 | Shares 33,218
Buy 21 May 2025
Value US$171,520.06 | Price 1.32 | Shares 129,684
Buy 20 May 2025
Value US$242,291.91 | Price 1.30 | Shares 187,098
Planned sale 26 Sep 2023
Value US$14,133.15 | Price 1.45 | Shares 9,747
Planned sale 26 Sep 2023
Value US$14,300.00 | Price 1.43 | Shares 10,000
Planned sale 26 Sep 2023
Value US$14,740.00 | Price 1.47 | Shares 10,000
Proposed sale 26 Sep 2023
Value US$49,102.80 | Price 1.45 | Shares 33,864
Planned sale 25 Sep 2023
Value US$286.00 | Price 1.43 | Shares 200
Sale 21 Sep 2023
Value US$144.00 | Price 1.44 | Shares 100
Sale 20 Sep 2023
Value US$593.28 | Price 1.44 | Shares 412
Sale 20 Sep 2023
Value US$4,937.25 | Price 1.45 | Shares 3,405
Sale 20 Sep 2022
Value US$28,668.80 | Price 1.70 | Shares 16,864
Sale 20 Sep 2022
Value US$29,013.90 | Price 1.71 | Shares 17,000
Buy 18 Oct 2021
Value US$7,999,992.00 | Price 14.00 | Shares 571,428
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-21 2026-05-20 B Purchase
1.8
Matheis Dennis
Non-Executive Director
29,043 +14.3%
128.43
US$4,897,925 		29,043 +14.3% 128.43 US$4,897,925
2025-08-22 2025-08-20 B Purchase
1.8
Matheis Dennis
Non-Executive Director
44,117 -49.9%
259.87
US$2,256,960 		44,117 -49.9% 259.87 US$2,256,960
2025-05-22 2025-05-22 B Purchase
1.8
Matheis Dennis
Non-Executive Director
82,752 -30.2%
496.81
US$3,742,378 		82,752 -30.2% 496.81 US$3,742,378
2025-05-22 2025-05-21 B Purchase
1.8
Matheis Dennis
Non-Executive Director
129,684 +69.3%
1.32
US$171,520 		129,684 +69.3% 1.32 US$171,520
2025-05-22 2025-05-20 B Purchase
1.8
Matheis Dennis
Non-Executive Director
187,098 +inf%
1.30
US$242,292 		187,098 +inf% 1.30 US$242,292
2023-09-27 2023-09-26 PlS Planned sale
2.9
Lapidus Stanley
Non-Executive Director
9,747 -8.8%
1.45
US$14,133 		9,747 -8.8% 1.45 US$14,133
2023-09-27 2023-09-26 PlS Planned sale
2.9
Lapidus Stanley
Non-Executive Director
10,000 -8.2%
1.43
US$14,300 		10,000 -8.2% 1.43 US$14,300
2023-09-27 2023-09-26 PlS Planned sale
2.9
Lapidus Stanley
Non-Executive Director
10,000 -7.6%
1.47
US$14,740 		10,000 -7.6% 1.47 US$14,740
2023-09-26 2023-09-26 PrS Proposed sale
2.9
Stanley N. Lapidus

Director

Non-Executive Director
33,864
1.45
US$49,103 		33,864 1.45 US$49,103
2023-09-27 2023-09-25 PlS Planned sale
2.9
Lapidus Stanley
Non-Executive Director
200 -0.2%
1.43
US$286 		200 -0.2% 1.43 US$286
2023-09-22 2023-09-21 S Sale
2.9
Lapidus Stanley
Non-Executive Director
100 -0.1%
1.44
US$144 		100 -0.1% 1.44 US$144
2023-09-22 2023-09-20 S Sale
2.9
Lapidus Stanley
Non-Executive Director
412 -0.3%
1.44
US$593 		412 -0.3% 1.44 US$593
2023-09-22 2023-09-20 S Sale
2.9
Lapidus Stanley
Non-Executive Director
3,405 -2.5%
1.45
US$4,937 		3,405 -2.5% 1.45 US$4,937
2022-09-22 2022-09-20 S Sale
2.9
Lapidus Stanley
Non-Executive Director
16,864 -11.1%
1.70
US$28,669 		16,864 -11.1% 1.70 US$28,669
2022-09-22 2022-09-20 S Sale
2.9
Lapidus Stanley
Non-Executive Director
17,000 -10.0%
1.71
US$29,014 		17,000 -10.0% 1.71 US$29,014
2021-10-20 2021-10-18 B Purchase
PAVmed Inc.
Large shareholder
571,428 +2.1%
14.00
US$7,999,992 		571,428 +2.1% 14.00 US$7,999,992
Explore more

More insider trading research around Lucid Diagnostics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America